Collectively, the inhibition of mitochondrial ROS-mediated NLRP3 inflammasome activation contributes to the protective effects of CA, which may be considered a potential therapeutic agent for septic ALI. The gene discussed is NLRP3; the disease is acute respiratory distress syndrome.